Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

NCT01148914 is registered in ClinicalTrials.gov with Texas Cardiac Arrhythmia Research Foundation as lead sponsor.

NCT NCT01148914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01148914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
Lead sponsor
Texas Cardiac Arrhythmia Research Foundation
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2012
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation